Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Merck
Pharma
Merck's Keytruda turns in mixed results in gynecological cancers
The company unveiled new data from separate studies in late stage cervical cancer and newly diagnosed endometrial cancer.
Zoey Becker
Sep 13, 2024 6:05pm
Merck's Welireg again comes up short in OS but excels in PFS
Sep 13, 2024 8:00am
Merck's Ebola vaccine proved effective in 2018 outbreak: study
Aug 22, 2024 7:50am
The TROP2 race for supremacy
Aug 16, 2024 9:45am
As Gardasil sales fall in China, Merck has few answers why
Jul 30, 2024 11:53am
FDA's ODAC calls for revamp of perioperative NSCLC trials
Jul 25, 2024 5:00pm
